Bryan, Garnier & Co is a European, full service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorised and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich and New York. The firm is a member of the London Stock Exchange and Euronext.
Overview
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 17, 2020 | Prolupin secures growth financing | Prolupin, the innovative plant-based protein company based in Grimmen, Germany, today announced the first closing of a double digit million growth financing round which will enable the company to expand its B2B and B2C offerings. After exce... |
Reviews 0
FAQ about Bryan, Garnier & Co
When was Bryan, Garnier & Co founded?
Bryan, Garnier & Co was founded in 1996.
What has the press written about Bryan, Garnier & Co?
Parsers VC has collected 2 articles mentioning Bryan, Garnier & Co, among them “Prolupin secures growth financing” (Mar 17, 2020).
Is Bryan, Garnier & Co still active?
Yes, Bryan, Garnier & Co is active; its latest activity on Parsers VC dates from Nov 14, 2025.